Not Medicare Enrolled

Dr. Azreena Thomas, MDPA

Neurology · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
8632 FREDERICKSBURG RD STE 112, San Antonio, TX 78240
2105930900
In practice since 2006 (20 years)
NPI: 1922078864 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Thomas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Thomas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Thomas

Dr. Azreena Thomas is a neurology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Thomas performed 32 Medicare services across 21 unique beneficiaries.

Between the years covered by Open Payments, Dr. Thomas received a total of $12,445 from 19 pharmaceutical and/or device companies across 196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Thomas is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 32 Medicare services $12,445 industry payments

Medicare Practice Summary

Medicare Utilization ↗
32
Medicare services
Bottom 4% in TX for neurology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
21
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min) 32 $85 $335
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,445
Total received (2018-2024)
Avg $1,778/year across 7 years
Top 24% in TX for neurology
19
Companies
196
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,014 (72.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,431 (27.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$77
2023
$528
2022
$3,332
2021
$580
2020
$3,406
2019
$1,101
2018
$3,421

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$9,715
Supernus Pharmaceuticals, Inc.
$570
SK Life Science, Inc.
$471
LivaNova USA, Inc.
$298
Greenwich Biosciences, Inc.
$253
Eisai Inc.
$237
EISAI INC.
$185
NeuroPace, Inc.
$125
Janssen Biotech, Inc.
$125
Neurelis, Inc.
$103
Lundbeck LLC
$100
Upsher-Smith Laboratories LLC
$63
Akcea Therapeutics, Inc.
$63
Novartis Pharmaceuticals Corporation
$34
EMD Serono, Inc.
$32
Avanir Pharmaceuticals, Inc.
$24
Marinus Pharmaceuticals, Inc.
$17
AQUESTIVE THERAPEUTICS, INC.
$15
Sunovion Pharmaceuticals Inc.
$15
Top 3 companies account for 86.4% of total payments
Associated products mentioned in payments ›
AFINITOR · AIMOVIG · Briviact · Cenobamate · DARZALEX · Epidiolex · Fintepla · Fycompa · NUEDEXTA · Nayzilam · ONFI · OXTELLAR XR · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · RNS System · SYMPAZAN · TEGSEDI · TROKENDI XR · VALTOCO · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · Vimpat · XCOPRI · ZTALMY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (72%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $38,889 per 100 Medicare services performed
Looking for a neurology specialist in San Antonio?
Compare neurologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
117
Per 100K population
5.7
County median income
$70,571
Nearest hospital
SAN ANTONIO BEHAVIORAL HEALTHCARE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Thomas is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Thomas experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Thomas performed 32 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Thomas receive payments from pharmaceutical companies?
Yes. Dr. Thomas received a total of $12,445 from 19 companies across 196 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Thomas's costs compare to other neurologists in San Antonio?
Dr. Thomas's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Thomas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →